Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.02450
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Harnessing the Immune System to Fight Cancer With Toll-Like Receptor and RIG-I-like Receptor Agonists

Pharmacological Research
Pharmacology
2020English

Tissue Factor and Toll-Like Receptor (TLR)4 in Hyperglycaemia-Hyperinsulinaemia

Thrombosis and Haemostasis
Hematology
2015English

Targeting Toll-Like Receptor-4 to Tackle Preterm Birth and Fetal Inflammatory Injury

Clinical and Translational Immunology
AllergyImmunologyNursing
2020English

Toll-Like Receptor (TLR)2 and TLR4 Agonists Regulate CCR Expression in Human Monocytic Cells

Journal of Immunology
AllergyImmunology
2004English

On the Edge: Targeting Toll-Like Receptor 2 in Ischemia/Reperfusion Injury

Circulation: Cardiovascular Interventions
Cardiovascular MedicineCardiology
2012English

Toll-Like Receptor System and Endometriosis

Journal of Obstetrics and Gynaecology Research
MedicineGynecologyObstetrics
2013English

Association Between Toll-Like Receptor 4 (Thr399Ile and Asp299Gly), Toll-Like Receptor 2 196-174 Deletion Polymorphisms With Cryptosporidiosis

Journal of Biosciences and Medicines
2016English

Toll-Like Receptor 2 (TLR2)

Science-Business eXchange
2009English

Methamphetamine Inhibits Toll-Like Receptor 9-Mediated Anti-Hiv Activity in Macrophages

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy